| Typicality: | 0.537 |
| Saliency: | 0.369 |
| before moving to pediatric indications | 7 | temporal |
| with spinal muscular atrophy | 5 | other |
| simultaneously | 3 | manner |
| drug → be approved for → adult | 36 |
| drug → be approved to treat → adult | 9 |
| drug → be approved in → adult | 3 |
| negative | neutral | positive |
| 0.139 | 0.567 | 0.295 |
| Raw frequency | 48 |
| Normalized frequency | 0.369 |
| Modifier score | 0.900 |
| Perplexity | 68.373 |